An innovative on-chip multi-sensing platform for single-use biopharmaceutical applicationsbroad
MultiSpek · Horizon Europe grant · 2025-01-01–2026-12-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2024-ACCELERATOR-02 · scheme HORIZON-EIC-ACC · topic HORIZON-EIC-2024-ACCELERATOROPEN-01. CORDIS record →
Objective
The growth of biomanufacturing, characterised by an ever-increasing number of bioproduced molecules including life-saving drugs, is hampered by high bioprocessing failure rates that incur over $2 billion in annual losses for companies like Johnson & Johnson. It is also associated with significant environmental impacts, particularly in sterilisation processes. Single-use technologies have emergedas a solution, yet they require advanced sensing capabilities for full effectiveness. InSpek addresses this need with its multi-sensoron- a-chip technology, utilising waveguide-enhanced Raman spectroscopy (WERS) and Photonic Integrated Circuits (PIC). Our PICsintegrate essential bioprocessing sensors — Raman spectroscopy, temperature, pH, dissolved oxygen, and others — into a single, compact platform. InSpek's non-invasive technology outperforms traditional sensors in cost and efficiency, enhancing real-time bioprocess monitoring and reducing the development time for new biotherapies.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| INSPEK | FR | coordinator | €2,491,233 | Yes |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.